Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.47 USD
−54.37 M USD
30.00 K USD
49.21 M
About ARS Pharmaceuticals, Inc.
Sector
CEO
Richard E. Lowenthal
Headquarters
San Diego
Website
Founded
2015
FIGI
BBG00FZQGXG3
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPRY is 15.20 USD — it has decreased by −0.39% in the past 24 hours. Watch ARS Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ARS Pharmaceuticals, Inc. stocks are traded under the ticker SPRY.
SPRY stock has risen by 1.13% compared to the previous week, the month change is a 7.19% rise, over the last year ARS Pharmaceuticals, Inc. has showed a 308.60% increase.
We've gathered analysts' opinions on ARS Pharmaceuticals, Inc. future price: according to them, SPRY price has a max estimate of 30.00 USD and a min estimate of 22.00 USD. Watch SPRY chart and read a more detailed ARS Pharmaceuticals, Inc. stock forecast: see what analysts think of ARS Pharmaceuticals, Inc. and suggest that you do with its stocks.
SPRY reached its all-time high on Mar 18, 2021 with the price of 63.41 USD, and its all-time low was 2.55 USD and was reached on Sep 20, 2023. View more price dynamics on SPRY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SPRY stock is 7.54% volatile and has beta coefficient of 2.74. Track ARS Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is ARS Pharmaceuticals, Inc. there?
Today ARS Pharmaceuticals, Inc. has the market capitalization of 1.47 B, it has decreased by −7.34% over the last week.
Yes, you can track ARS Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ARS Pharmaceuticals, Inc. is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
SPRY earnings for the last quarter are −0.13 USD per share, whereas the estimation was −0.11 USD resulting in a −17.51% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about ARS Pharmaceuticals, Inc. earnings.
ARS Pharmaceuticals, Inc. revenue for the last quarter amounts to 500.00 K USD, despite the estimated figure of 1.00 M USD. In the next quarter, revenue is expected to reach 575.00 K USD.
SPRY net income for the last quarter is −12.52 M USD, while the quarter before that showed −10.29 M USD of net income which accounts for −21.61% change. Track more ARS Pharmaceuticals, Inc. financial stats to get the full picture.
No, SPRY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 26.00 employees. See our rating of the largest employees — is ARS Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARS Pharmaceuticals, Inc. EBITDA is −56.67 M USD, and current EBITDA margin is −224.82 K%. See more stats in ARS Pharmaceuticals, Inc. financial statements.
Like other stocks, SPRY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARS Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARS Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARS Pharmaceuticals, Inc. stock shows the buy signal. See more of ARS Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.